Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults With Cancer

NCT05228275 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT05228275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05228275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults With Cancer
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Active, not recruiting
Start date
April 8, 2022
Completion date
March 31, 2028
Enrollment
549 (estimated)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, hematopoietic and lymphatic system neoplasm, malignant solid neoplasm